REGENXBIO Inc.
RGNX· Nasdaq
RGNXREGENXBIO Inc.
Source filing unavailable
| Metric | Q2 2015 | Q2 2014 |
|---|---|---|
| Revenue | $1.36M | $1.55M |
| Net Income | -$6.29M | -$672.00K |
| EPS Diluted | -$3.24 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
REGENXBIO Inc. · CIK 1590877 · Engraved from SEC EDGAR
